Literature DB >> 966151

Influence of cholestasis on drug elimination: pharmacokinetics.

L I Harrison, M Gibaldi.   

Abstract

A two-compartment model representing the body and the GI tract, with elimination occurring in each compartment, was used to study, in theory, the influence of impaired biliary excretion on drug disposition. The results suggest that cholestasis can either increase or decrease a drug's half-life, depending upon the relative values of the two elimination rate constants, In all cases, however, impaired biliary excretion reduced the initial elimination of drug from the body and increased the half-life of the alpha-phase of drug disposition.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 966151     DOI: 10.1002/jps.2600650921

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  11 in total

Review 1.  Pharmacokinetic changes during pregnancy and their clinical relevance.

Authors:  R Loebstein; A Lalkin; G Koren
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

2.  Zero-order absorption and linear disposition of oral colchicine in healthy volunteers.

Authors:  G Thomas; C Girre; J M Scherrmann; P Francheteau; J L Steimer
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  A variable reabsorption time-delay model for pharmacokinetics of drugs.

Authors:  C Labat; K Mansour; M F Malmary; M Terrissol; J Oustrin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Apr-Jun       Impact factor: 2.441

Review 4.  Drug kinetics in pregnancy.

Authors:  B Krauer; F Krauer
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

5.  Mean residence time for drugs subject to enterohepatic cycling.

Authors:  T A Shepard; G F Lockwood; L J Aarons; I D Abrahams
Journal:  J Pharmacokinet Biopharm       Date:  1989-06

6.  Effect modelling for drugs undergoing enterohepatic circulation.

Authors:  P Höglund; M Ohlin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Oct-Dec       Impact factor: 2.441

7.  Estimation of area under the curve for drugs subject to enterohepatic cycling.

Authors:  T A Shepard; R H Reuning; L J Aarons
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

Review 8.  Effect of Liver Disease on Hepatic Transporter Expression and Function.

Authors:  Nilay Thakkar; Jason R Slizgi; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2017-04-30       Impact factor: 3.534

9.  Pharmacokinetic interpretation of the enterohepatic recirculation and first-pass elimination of morphine in the rat.

Authors:  B E Dahlström; L K Paalzow
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

10.  The pharmacokinetics of alpha-methyldopa in dogs.

Authors:  G M Kochak; W D Mason
Journal:  J Pharmacokinet Biopharm       Date:  1985-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.